New Meds and Tech: Increlex

In response to findings of a safety signal report that there is reasonable suspicion of a causal association between use of Increlex® and childhood neoplasia, including malignancy,…

Read More

New Meds and Tech: Glucagon Preparations

The FDA has approved two new ready to use forms of glucagon and these have been introduced to the market: an intranasal powder (Baqsimi, Eli Lilly)…

Read More

New Meds and Tech: Vitamin D Preparations and Safety Issues

Vitamin D is a fat soluble vitamin that is essential for maintaining bone health and also has other potential health benefits. While some of these other…

Read More

New Meds and Tech: Tirosint-SOL

Levothyroxine sodium oral solution (Tirosint-SOL) has now been approved by the FDA and is available for use in the US. Please click on the link below for…

Read More

Improving Long-Term Outcomes of Youth with Lipid Abnormalities – Expanding the Role of Pediatric Endocrinologists

Read More

Treatment of Adolescent Obesity in 2020

A brief synopsis of available treatments for pediatric obesity.

Read More

2018 Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice

Read More

Hypogonadism in Children with a Previous History of Cancer: Endocrine Management and Follow-Up (HRP 2019)

Read More

Childhood Cancer Treatments and Associated Endocrine Late Effects: A Concise Guide for the Pediatric Endocrinologist (HRP 2019)

Read More

Long-Term Endocrine and Metabolic Consequences of Cancer Treatment: A Systematic Review

Read More